Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
100%(6 trials)

Phase Distribution

Ph phase_2
2
33%
Ph not_applicable
1
17%
Ph phase_1
3
50%

Phase Distribution

3

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
2(33.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (50.0%)
Phase 22 (33.3%)
N/A1 (16.7%)

Trials by Status

completed6100%

Recent Activity

0 active trials
Showing 5 of 6
completednot_applicable

Mucinex® for Treatment of Filamentary Keratitis

NCT02859246
completedphase_1

Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h

NCT03642262
completedphase_1

Mucinex® ER 600 mg Bi-Layer Tablet Fed and Fasted

NCT03649750
completedphase_1

Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release Tablet

NCT03633487
completedphase_2

Evaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory Infection

NCT01114581
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT02859246Not Applicable

Mucinex® for Treatment of Filamentary Keratitis

Completed
NCT03642262Phase 1

Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h

Completed
NCT03649750Phase 1

Mucinex® ER 600 mg Bi-Layer Tablet Fed and Fasted

Completed
NCT03633487Phase 1

Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release Tablet

Completed
NCT01114581Phase 2

Evaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory Infection

Completed
NCT01537081Phase 2

Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6